<DOC>
	<DOCNO>NCT00003417</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Computer system allow doctor create 3-dimensional picture tumor order plan treatment may result effective radiation therapy . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining radiation therapy chemotherapy may kill tumor cell . PURPOSE : Phase I/II trial study effectiveness radiation therapy plan computer plus chemotherapy treating patient glioblastoma multiforme .</brief_summary>
	<brief_title>Computer Planned Radiation Therapy Plus Chemotherapy Treating Patients With Glioblastoma Multiforme</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility toxicity escalate dos conformal radiotherapy plan 3-D treatment planning plus carmustine patient glioblastoma multiforme . - Determine dose/volume dose/anatomic characteristic influence radiotherapy-induced CNS ( central nervous system ) toxicity . - Evaluate local control , survival , failure pattern patient treat high dos conformal radiotherapy gross disease . - Correlate change cross-sectional diagnostic MRI image study clinical biologic endpoint . OUTLINE : This dose-escalation study . Patients stratify accord plan target volume , i.e. , gross residual tumor plus 3 mm ( le 75 cc v least 75 cc ) . Patients undergo radiotherapy 15-30 minute daily 5 day week 6-8 week . After 46 Gy radiotherapy administer , patient undergo radiotherapy field reduction accrue one four dose level . ( Dose level 1 close accrual 1/16/01 ) All patient receive least 33 radiation treatment . Each patient evaluate acute dose-limiting toxicity 90 day start therapy . Patients also receive carmustine IV 1-2 hour daily day 1-3 first week radiotherapy . Treatment repeat every 8 week 6 course . Patients follow every 4 month 2 year , every 6 month 1 year , annually thereafter . PROJECTED ACCRUAL : A total 40 patient ( 20 per arm ) accrue study within least 5 month .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm glioblastoma multiforme area necrosis diagnosed surgical biopsy subtotal excision Supratentorial tumor Gross measurable residual disease No welldifferentiated anaplastic astrocytoma , multifocal glioma , recurrent glioblastoma multiforme Therapy must begin within 5 week surgery within 1 week registration CT MRI scan preoperatively MRI postoperatively prior initiation radiotherapy If undergoing stereotacticguided needle biopsy , require repeat MRI procedure prebiopsy MRI suitable treatment plan Prior complete surgical resection tumor allow PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hemoglobin least 9 g/dL Hepatic : Bilirubin great 2 mg/dL SGPT ( serum glutamate pyruvate transaminase ) SGOT ( serum glutamic oxaloacetic transaminase ) great 2 time normal Renal : BUN ( blood urea nitrogen ) great 30 mg/dL Creatinine great 1.8 mg/dL Pulmonary : Normal chest xray OR DLCO ( carbon monoxide diffuse capacity ) least 60 % predict Other : Not pregnant Negative pregnancy test Fertile patient must use effective contraception No malignancy within past 5 year except carcinoma situ cervix bladder , ductal carcinoma situ breast , nonmelanomatous skin cancer Neurologic functional status 03 No major medical illness psychiatric impairment would preclude study participation PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior systemic chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy head neck Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>